Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study-Reference-Cited by-同舟云学术

Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study

Published:2024 Issue:1 Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Chen Tingting¹²^ORCID,Xu Junfen¹²^ORCID,Xia Bairong³^ORCID,Wang Hui¹²⁴^ORCID,Shen Yuanming¹²⁴^ORCID

Affiliation:

1. Department of Gynecology and Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

2. Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

3. Department of Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

4. Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, Zhejiang, China.

Funder

Natural Science Foundation of Zhejiang Province

Zhejiang University School of Medicine

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e22

Reference23 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance

3. Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer

4. Treatment of epithelial ovarian cancer

5. Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients